Celon Pharma S.A. (CLN.WA)

PLN 23.85

(-7.38%)

Net Debt Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual net debt in 2023 was -6.76 Million PLN , up 87.93% from previous year.
Celon Pharma S.A.'s latest quarterly net debt in 2024 Q2 was -29.87 Million PLN , down -275.21% from previous quarter.
Celon Pharma S.A. reported annual net debt of -56.08 Million PLN in 2022, up 57.8% from previous year.
Celon Pharma S.A. reported annual net debt of -132.87 Million PLN in 2021, down -535.57% from previous year.
Celon Pharma S.A. reported quarterly net debt of -7.96 Million PLN for 2024 Q1, down -17.62% from previous quarter.
Celon Pharma S.A. reported quarterly net debt of -5.3 Million PLN for 2023 Q3, down -62.87% from previous quarter.

Annual Net Debt Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Net Debt of Celon Pharma S.A. (2023 - 2012)

Year	Net Debt	Net Debt Growth
2023	-6.76 Million PLN	87.93%
2022	-56.08 Million PLN	57.8%
2021	-132.87 Million PLN	-535.57%
2020	-20.9 Million PLN	67.85%
2019	-65.03 Million PLN	55.77%
2018	-147.04 Million PLN	25.6%
2017	-197.63 Million PLN	7.72%
2016	-214.17 Million PLN	-2114.37%
2015	10.63 Million PLN	152.9%
2014	4.2 Million PLN	220.65%
2013	-3.48 Million PLN	41.44%
2012	-5.95 Million PLN	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-29.87 Million PLN	-275.21%
2024 Q1	-7.96 Million PLN	-17.62%
2023 Q3	-5.3 Million PLN	-62.87%
2023 Q1	-22.73 Million PLN	59.46%
2023 Q4	-6.76 Million PLN	-27.52%
2023 FY	-6.76 Million PLN	87.93%
2023 Q2	-3.25 Million PLN	85.67%
2022 Q2	-94.66 Million PLN	12.63%
2022 FY	-56.08 Million PLN	57.8%
2022 Q4	-56.08 Million PLN	2.48%
2022 Q1	-108.35 Million PLN	18.46%
2022 Q3	-57.5 Million PLN	39.26%
2021 Q2	2.1 Million PLN	114.34%
2021 Q4	-132.87 Million PLN	34.65%
2021 Q3	-203.34 Million PLN	-9782.86%
2021 Q1	-14.64 Million PLN	29.96%
2021 FY	-132.87 Million PLN	-535.57%
2020 FY	-20.9 Million PLN	67.85%
2020 Q4	-20.9 Million PLN	-20.27%
2020 Q3	-17.38 Million PLN	-18.85%
2020 Q2	-14.62 Million PLN	73.19%
2020 Q1	-54.55 Million PLN	16.11%
2019 Q1	-145.03 Million PLN	1.36%
2019 FY	-65.03 Million PLN	55.77%
2019 Q4	-65.03 Million PLN	16.38%
2019 Q3	-77.76 Million PLN	26.55%
2019 Q2	-105.88 Million PLN	27.0%
2018 FY	-147.04 Million PLN	25.6%
2018 Q2	-178.95 Million PLN	6.67%
2018 Q3	-157.88 Million PLN	11.78%
2018 Q1	-191.74 Million PLN	2.98%
2018 Q4	-147.04 Million PLN	6.87%
2017 Q1	-217.7 Million PLN	-1.65%
2017 Q2	-208.21 Million PLN	4.36%
2017 Q3	-204.06 Million PLN	1.99%
2017 Q4	-197.63 Million PLN	3.15%
2017 FY	-197.63 Million PLN	7.72%
2016 FY	-214.17 Million PLN	-2114.37%
2016 Q4	-214.17 Million PLN	-3910.98%
2016 Q1	3.19 Million PLN	-60.88%
2016 Q3	5.62 Million PLN	0.0%
2015 Q4	8.17 Million PLN	0.0%
2015 FY	10.63 Million PLN	152.9%
2014 FY	4.2 Million PLN	220.65%
2013 FY	-3.48 Million PLN	41.44%
2012 FY	-5.95 Million PLN	0.0%

Peer Net Debt Comparison of Celon Pharma S.A.

Name	Net Debt	Net Debt Difference